InnoSpina is a privately held medical device start-up founded in 2017 dedicated to the advancement of minimally invasive (MIS) and motion preserving technologies for disorders of the spine. The company currently focuses on new ways to treat Lumbar Spinal Stenosis which is the most common reason for spinal surgery in patient over 65 years old. After 3
years of research, InnoSpina developed a first a first innovative implant combined with a simplified, safe and quick implantation procedure (pre-clinically validated) that can lead to a reduction of surgical time up to 78% as compared to current golden standard such as spinal fusion or a Coflex® implant. It was recently granted a 1.3M Innosuisse project to further develop and increase the competitive edge of its first implant.